Skip to content

Caffeine citrate

Cafcit, Nymusa, Peyona (caffeine, citrated) is a small molecule pharmaceutical. Caffeine, citrated was first approved as Cafcit on 1999-09-21. It has been approved in Europe to treat apnea. The pharmaceutical is active against adenosine receptor A2a, adenosine receptor A3, adenosine receptor A2b, and adenosine receptor A1.
Trade Name Nymusa, Peyona
Common Name Caffeine citrate
Indication apnea
Drug Class
Caffeine citrate
Get full access now